| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |